Cortactin knockdown results in decreased FA turnover. by Alok Tomar (139282)

Diabetic kidney shows decreased klotho expression. by Jeong Suk Kang (7359572)

“…<p>(a) Representative images of the kidney from normal and diabetic biopsies showing the decreased klotho expression in diabetic podocytes by IHC. …”

Sodium taurocholate decreased higher order oligomerization. by Eunhee Lee (804130)

Nicotine-induced Tumor Growth is decreased by BEL. by Lindsay E. Calderon (332344)

STZ Decreases Akt Activity in Rat Striatum by Jason M Williams (61649)

Tranilast decreases OC formation induced by RANKL. by Tien Van Phan (583324)

ACOT1 decreases ROS in rodent heart. by Shenglan Yang (112488)

BA decreases DUB activity in PC cells. by Teresita Reiner (281437)

“…<p>(<b>A</b>) Western blot analysis showed that BA treatment of LNCaP cells (24 h) increased total poly-Ub proteins similar to MG132 treated cells. …”

Laquinimod prevents EAE and decreases encephalitogenicity of T cells. by Ulf Schulze-Topphoff (174453)

“…<p>DBA/1 (A) mice and C57BL/6 mice (B) were treated daily with laquinimod (25 mg/kg, n = 6/group) or vehicle (water, n = 6/group) starting from the day of immunization with rMOG 1-125 (DBA/1) or MOG p35-55 (C57BL/6). …”

Tranilast decreases RANKL-induced ROS level. by Tien Van Phan (583324)

TH5487 decreases RSV replication in lungs. by Lang Pan (5145221)

Microglia-conditioned medium decreases NPC viability. by Johanna Mäkelä (223358)

<b>Diroximel fumarate acts through Nrf2 to attenuate methylglyoxal-induced nociception in mice and decrease ISR activation in DRG neurons</b> by Muhammad Saad Yousuf (20745168)

In the null model the event rate does not decrease as a function of the inverse of time. by Thomas O. Richardson (251876)

A2EN supernatants do not decrease cell-free HIV viability. by Lyndsey R. Buckner (843006)

AGE-modification of laminin leads to a decrease in Kir4.1 function. by Kayla Thompson (4885036)

Carvacrol-induced hypothermia is associated with a decrease in whole-body energy production. by Viktor V. Feketa (821190)

Effects of Pitavastatin on Lipid Profiles in HIV-Infected Patients with Dyslipidemia and Receiving Atazanavir/Ritonavir: A Randomized, Double-Blind, Crossover Study by Asita Wongprikorn (2837378)

“…At 12 weeks of treatment with pitavastatin compared to placebo; mean [95% confidence interval (CI)] total cholesterol (TC) was 207 (187.3, 226.8) mg/dL vs 246.3 (226.5, 266) mg/dL (<i>p</i> <0.001); mean (95% CI) triglyceride (TG) was 351.3 (193.2, 509.4) mg/dL vs 279.1 (121, 437.2) mg/dL (<i>p</i> = 0.269); mean (95% CI) high density lipoprotein (HDL) was 45.3 (40.4, 50.2) mg/dL vs 44.2 (39.3, 49.1) mg/dL (<i>p</i> = 0.354); and mean (95% CI) low density lipoprotein (LDL) was 113.2 (100.4, 126) mg/dL vs 145.6 (132.8, 158.4) mg/dL (<i>p</i> <0.001). …”

CD47 expression is decreased in hematopoietic progenitor cells in patients with myelofibrosis by A. Nonino (6072632)

T198A/G substitution markedly decrease p27 protein stability. by Monica Schiappacassi (227672)